|
Patient education
programs designed to give sufferers of rheumatoid arthritis strategies
and tools to help cope with their disease produce only small,
short-lived benefits, according to an editorial appearing in the
British Medical Journal.
A recent review
assessed the effectiveness of education programs in patients with
rheumatoid arthritis, based on a systematic study of the various
clinical trials. The review focused on the effects of patient
education on pain, disability, number of joints with pain, patients'
and doctors' assessments, as well as other measurements of the
disease.
Small, but
statistically significant, benefits of patient education were
seen for scores on disability, joint counts, patients' global
assessment, psychological status, and depression.
However, patient
education was found to have two major drawbacks, according to
the authors. First, its statistically significant benefits are
modest. In comparison to no intervention, patient education gave
a 4 percent decrease in pain, 10 percent improvement in disability,
12 percent improvement on depression scores, and other small improvements
according to various indexes.
Secondly,
the benefits of patient education are short lived. At final follow-up
(up to one year after the intervention) no significant benefits
were found. Even studies that included "booster sessions"
did not demonstrate long-term benefits.
"Available
evidence about patient education programs for adults with rheumatoid
arthritis shows that these programs have clear but relatively
small benefits that are short lived," concluded the researchers.
"Their clinical significance is unclear, as are the relations
between changes in behavior and changes in health outcomes."
Other
sources: British Medical Journal
|